NIR Denies Part In Alleged Kickbacks Case

Oct 13 2010 | 11:19am ET

NIR Group, which faces a kickbacks probe itself, is denying any knowledge of a kickback scheme at Ingen Technologies.

The Securities and Exchange Commission last week charged Ingen and CEO Scott Sand with paying a pension fund manager and an associate to buy Ingen stock in an effort to boost its price. According to the regulator, Sand paid kickbacks that amounted to 30% of the $40,000 in purchase prices—more than $12,000—to the pension fund, Benefits and Pension Group.

Unfortunately for Sand and Ingen, Benefits and Pensions was set up by the Federal Bureau of Investigation.

And unfortunately for NIR, it was one of the medical device maker's largest investors. The hedge fund is being investigated for allegedly paying kickbacks to help it inflate the value of some of its hedge funds, and some investors have accused the Roslyn, N.Y.-based firm invented its returns, though it is unclear whether authorities have linked the Ingen kickbacks to NIR.

Neither NIR nor founder Corey Ribotsky has been charged with any wrongdoing, but a former NIR analyst in July pleaded guilty to taking kickbacks and fraud.

The hedge fund is also denying any knowledge of or participation in the alleged Ingen kickback scheme, according to The PIPES Report. In fact, NIR said that it had sued Ingen last year "due to its failure to honor its obligations to NIR."


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

The healthcare sector went on a tear beginning in 2011, thanks in large part to the passage of the Affordable Care Act and its impending implementat